Fred E Cohen insider trades
Open-market stock purchases and sales by Fred E Cohen, Unknown at CareDx, Inc, from SEC Form 4 filings since Jun 11, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +25%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 12, 2026 | CDNA CareDx, Inc | Bought (not open market) | — |
| Jun 9, 2026 | NTLA Intellia Therapeutics, Inc | Bought (not open market) | — |
| Jun 9, 2026 | NTLA Intellia Therapeutics, Inc | Bought (not open market) | — |
| May 27, 2026 | KYTX Kyverna Therapeutics, Inc | Bought (not open market) | — |
| May 27, 2026 | KYTX Kyverna Therapeutics, Inc | Bought (not open market) | — |
| Jan 5, 2026 | NTLA Intellia Therapeutics, Inc | Bought | $1.4M |
Companies traded
- CDNA CareDx, Inc: other filings, last Jun 12, 2026
- NTLA Intellia Therapeutics, Inc: 1 buy, last Jun 9, 2026
- KYTX Kyverna Therapeutics, Inc: other filings, last May 27, 2026
- URGN UroGen Pharma Ltd: other filings, last Aug 6, 2024
- PGNY Progyny, Inc: other filings, last May 23, 2024
- VCYT Veracyte, Inc: 2 sales, last Oct 19, 2020
- GHDX Genomic Health Inc: 13 sales, last Nov 8, 2019
- TNDM Tandem Diabetes Care Inc: other filings, last Nov 15, 2018
- BCRX Biocryst Pharmaceuticals Inc: 1 sale, last Jun 20, 2018
- ROKA Roka BioScience, Inc: other filings, last Jun 28, 2017
- FPRX Five Prime Therapeutics Inc: other filings, last May 10, 2017